Copyright
©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4020-4032
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4020
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4020
Table 1 MDCT scan parameters
Group | Scan protocol/parameters |
Scan area | From diaphragm top to lower edge of symphysis pubis |
Body position | Supine position |
Tube voltage (kV)/tube current (mAs) | 120/care dose 4D |
Linear fusion coefficient | 0.5 |
Pitch | 1.0 |
Rotate speed | 0.5 s |
Collimation (mm) | 2 × 192 × 0.6 |
Thickness of collection layer (mm) | 1 mm |
Interlayer spacing | 0.6 mm |
Convolution kernel | Br40 |
Enhancement protocol | Arterial phase (automatic tracking technology: when the aortic monitoring threshold reached 100 HU, the arterial phase scan was triggered); intravenous phase (scan started 75 s after the contrast agent was injected) |
Contrast agent (concentration) | Iopromide (370 mgI/mL) |
Dose and rate of contrast agent administration | 1.5 mL/kg, 3.5 mL/s |
Table 2 The demographic characteristics of death and survival groups
Total number (n = 53) | Survival group (n = 44) | Death group (n = 9) | P value | |
Sex (%) | 0.938 | |||
Male | 33 (62.3) | 28 (52.8) | 5 (9.4) | |
Female | 20 (37.7) | 16 (30.2) | 4 (7.5) | |
Smoking (%) | 1.000 | |||
No | 35 (66.0) | 29 (54.7) | 6 (11.3) | |
Yes | 18 (34.0) | 15 (28.3) | 3 (5.7) | |
Alcohol (%) | 0.667 | |||
No | 35 (66.0) | 28 (52.8) | 7 (13.2) | |
Yes | 18 (34.0) | 16 (30.2) | 2 (3.8) | |
Diabetes (%) | 0.978 | |||
No | 44 (83.0) | 36 (67.9) | 8 (15.1) | |
Yes | 9 (17.0) | 8 (15.1) | 1 (1.9) | |
Hypertension (%) | 1.000 | |||
No | 27 (50.9) | 22 (41.5) | 5 (9.4) | |
Yes | 26 (49.1) | 22 (41.5) | 4 (7.5) | |
Heart disease (%) | 1.000 | |||
No | 26 (49.1) | 22 (41.5) | 4 (7.5) | |
Yes | 27 (50.9) | 22 (41.5) | 5 (9.4) | |
Surgery (%) | 0.395 | |||
No | 38 (71.7) | 30 (56.6) | 8 (15.1) | |
Yes | 15 (28.3) | 14 (26.4) | 1 (1.9) | |
Vomitus (%) | 0.938 | |||
No | 20 (37.7) | 16 (30.2) | 4 (7.5) | |
Yes | 33 (62.3) | 28 (52.8) | 5 (9.4) | |
Age (yr) | 74 (63.50, 80.50) | 72 (62.25, 80.00) | 75 (73.00, 82.00) | 0.231 |
Abdominal pain duration (d) | 1.00 (1.00, 5.00) | 2.00 (1.00, 5.00) | 1.00 (0.75, 2.00) | 0.298 |
Body temperature at admission (℃) | 36.7 (36.5, 37.7) | 36.6 (36.4, 37.3) | 37.7 (36.6, 38.4) | 0.055 |
Table 3 Biochemical indicators of death and survival groups
Total number (n = 53) | Survival group (n = 44) | Death group (n = 9) | P value | |
D-dimer > 1000 μg/mL (%) | 0.499 | |||
No | 20 (37.7) | 18 (34.0) | 2 (3.8) | |
Yes | 33 (62.3) | 26 (49.1) | 7 (13.2) | |
Blood lactate > 2.1 mmol/L (%) | 0.004 | |||
No | 44 (83.0) | 40 (75.5) | 4 (7.5) | |
Yes | 9 (17.0) | 4 (7.5) | 5 (9.4) | |
Blood pH < 7.35 (%) | 0.004 | |||
No | 47 (88.7) | 42 (79.2) | 5 (9.4) | |
Yes | 6 (11.3) | 2 (3.8) | 4 (7.5) | |
Blood amylase > 110 U/L (%) | 0.027 | |||
No | 32 (84.2) | 29 (76.3) | 3 (7.9) | |
Yes | 6 (15.8) | 3 (7.9) | 3 (7.9) | |
Serum creatinine > 120 μmol/L (%) | 0.097 | |||
No | 36 (78.3) | 32 (69.6) | 4 (8.7) | |
Yes | 10 (21.7) | 6 (13.0) | 4 (8.7) | |
White blood cell | 10.6 (6.95, 15.45) | 9.1 (6.73, 16.48) | 10.7 (9.2, 14.6) | 0.362 |
Red blood cell | 4.19 (3.89, 4.64) | 4.18 (3.97, 4.63) | 4.48 (3.60, 4.94) | 0.887 |
Neutrophil | 8.5 (5.42, 13.66) | 7.55 (5.36, 14.46) | 9.42 (7.75, 12.90) | 0.236 |
Lymphocyte | 0.9 (0.6, 1.2) | 0.90 (0.60, 1.20) | 0.70 (0.55, 1.20) | 0.392 |
Neutrophil/lymphocyte | 9.3 (6.00, 16.22) | 8.47 (5.48, 16.42) | 13.46 (8.52, 17.33) | 0.169 |
Total protein | 64.4 (56.55, 70.85) | 64.2 (56.73, 69.45) | 67.0 (51.3, 76.05) | 0.713 |
Albumin to total protein ratio | 1.20 (1.0, 1.3) | 1.20 (1.00, 1.38) | 1.10 (1.00, 1.30) | 0.516 |
Blood glucose | 6.90 (5.65, 8.44) | 6.8 (4.93, 8.44) | 7.70 (6.90, 16.28) | 0.107 |
Table 4 Comparison of multidetector computed tomography reading results of two radiologists
Total number | A | B | P value | |
Embolus involvement length (%) | ||||
≤ 20 mm | 14 | 6 | 13 | 0.014 |
20-50 mm | 11 | 10 | 11 | 1 |
≥ 50 mm | 28 | 25 | 28 | 0.236 |
Embolus region (%) | ||||
I | 5 | 4 | 5 | 1 |
II | 1 | 1 | 1 | 1 |
III | 2 | 0 | 2 | 0.024 |
IV | 8 | 3 | 7 | |
I + II | 2 | 2 | 2 | 1 |
III + IV | 19 | 18 | 19 | 1 |
I + II + III | 1 | 1 | 1 | 1 |
II + III + IV | 7 | 6 | 7 | 1 |
I + II + III + IV | 8 | 8 | 8 | 1 |
Extravascular signs (%) | ||||
Decreased intestinal wall enhancement | 30 | 24 | 28 | 0.255 |
Intestinal wall thinning | 22 | 9 | 14 | 0.131 |
Intestinal wall thickening | 14 | 14 | 14 | 1 |
Pneumatosis intestinalis | 5 | 3 | 3 | 1 |
Infarction of the organs | 22 | 18 | 22 | 0.108 |
Mesenteric fat stranding | 29 | 25 | 27 | 0.67 |
Table 5 Comparison of multidetector computed tomography signs in death and survival groups
Survival group (n = 44) | Death group (n = 9) | P value | |
Embolus involvement length (%) | 0.311 | ||
≤ 20 mm | 12 (27.27) | 1 (11.11) | |
20-50 mm | 10 (22.73) | 1 (11.11) | |
≥ 50 mm | 22 (50.00) | 7 (77.78) | |
Embolus region (%) | 0.212 | ||
I | 4 (9.09) | 1 (11.11) | |
II | 1 (2.27) | 0 (0) | |
III | 2 (4.55) | 0 (0) | |
IV | 8 (18.18) | 0 (0) | |
I + II | 1 (2.27) | 1 (11.11) | |
III + IV | 17 (38.64) | 2 (22.22) | |
I + II + III | 1 (2.27) | 0 (0) | |
II + III + IV | 6 (13.64) | 1 (11.11) | |
I + II + III + IV | 4 (9.09) | 4 (44.44) | |
Decreased intestinal wall enhancement (%) | 0.004 | ||
No | 23 (52.27) | 0 (0) | |
Yes | 21 (47.73) | 9 (100) | |
Intestinal wall thinning (%) | 0.002 | ||
No | 30 (68.18) | 1 (11.11) | |
Yes | 14 (31.82) | 8 (88.89) | |
Intestinal wall thickening (%) | 0.178 | ||
No | 34 (77.27) | 5 (55.56) | |
Yes | 10 (22.73) | 4 (44.44) | |
Pneumatosis intestinalis (%) | 0.007 | ||
No | 42 (95.45) | 6 (66.67) | |
Yes | 2 (4.55) | 3 (33.33) | |
Infarction of other organs (%) | 0.348 | ||
No | 27 (61.36) | 4 (44.44) | |
Yes | 17 (38.64) | 5 (55.56) | |
Mesenteric fat stranding (%) | 0.127 | ||
No | 22 (50) | 2 (22.22) | |
Yes | 22 (50) | 7 (77.78) |
Table 6 Univariate cox regression
HR | 95%CI | P value | |
Intestinal wall thinking | 2.27 | (0.61-8.45) | 0.223 |
Intestinal wall thinning | 13.35 | (1.54-99.01) | 0.018 |
Pneumatosis intestinalis | 5.73 | (1.41-23.35) | 0.015 |
Other organ infarction | 1.79 | (0.48-6.67) | 0.386 |
mesenteric fat stranding | 2.96 | (0.62-14.27) | 0.176 |
Blood lactate > 2.1 mmol/L | 6.82 | (1.82-25.60) | 0.004 |
Blood pH < 7.35 | 7.36 | (1.94-27.86) | 0.003 |
Embolus distribution region (multi-classification variable) | 1.42 | (0.92-1.74) | 0.156 |
Embolus involvement length | |||
20-50 mm (vs ≤ 20 mm) | 1.09 | (0.07-17.50) | 0.951 |
≥ 50 mm (vs ≤ 20 mm) | 3.14 | (0.39-25.54) | 0.284 |
Table 7 Multivariate cox regression
Model1 | Model2 | Model3 | ||||||||
HR | 95%CI | P value | HR | 95%CI | P value | HR | 95%CI | P value | ||
Intestinal wall thinning | 9.40 | (1.05-83.46) | 0.044 | 9.66 | (1.15-81.03) | 0.037 | 11.01 | (1.32-92.22) | 0.027 | |
Pneumatosis intestinalis | 4.58 | (0.86-24.36) | 0.074 | 6.09 | (1.25-29.69) | 0.025 | 6.01 | (1.25-28.97) | 0.025 | |
Blood lactate > 2.1 mmol/L | 5.26 | (1.04-26.69) | 0.045 | 5.21 | (1.12-24.22) | 0.035 | 6.34 | (1.56-25.73) | 0.010 | |
Blood pH < 7.35 | 4.84 | (0.94-25.09) | 0.060 | 5.59 | (1.26-24.88) | 0.024 | 6.26 | (1.47-26.59) | 0.013 |
- Citation: Yang JS, Xu ZY, Chen FX, Wang MR, Cong RC, Fan XL, He BS, Xing W. Role of clinical data and multidetector computed tomography findings in acute superior mesenteric artery embolism. World J Clin Cases 2022; 10(13): 4020-4032
- URL: https://www.wjgnet.com/2307-8960/full/v10/i13/4020.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i13.4020